PubHawk
Cardiovasc Diabetol April 2023 PMID 37055837

Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms.

Keming Huang, Xianling Luo, Bin Liao, Guang Li, Jian Feng

Download social card

Mentions

5
Peak: 1 in Apr 2023
across 3 sources since Apr 2023

Extended reach

1,603
potential audience

Total likes

12

Video views

14

Mentions per month

Apr 2023 – Jul 2023

Where it's discussed

  • X / Twitter2 posts
  • News2 articles
  • YouTube1 videos

AI synopsis

What people are saying

The comments highlight the mechanisms of SGLT2 inhibitors as effective for diabetic cardiomyopathy, using positive phrases like 'great summary' and 'more evidence for effectiveness,' which reflect appreciation and recognition of the importance of the findings. The tone is optimistic and interested, emphasizing the potential clinical impact of these results.

AgreementModerate agreement

The discussions generally agree that SGLT2 inhibitors are effective in improving cardiac function related to diabetes.

InterestModerate interest

Participants show a moderate level of interest, appreciating the detailed mechanisms discussed in the publication.

EngagementModerate engagement

Posts include expressions of approval and summaries of the article, indicating a fair level of engagement.

ImpactModerate impact

The discussions suggest that the publication contributes meaningfully to ongoing research and interest in diabetes treatments.

Abstract in brief

  • SGLT2 inhibitors (SGLT2i) are shown to improve various heart-related issues caused by diabetes, such as problems with metabolism, circulation, and cell health.
  • The treatment helps reduce heart muscle damage by targeting multiple cellular processes like fibrosis, oxidative stress, and cell death, as well as improving gut health.
  • This review consolidates current understanding of how SGLT2i work to combat diabetic cardiomyopathy at the molecular and cellular levels.]
Read the full abstract

Top posts

Most liked on X and Bluesky
Subodh Verma
@SubodhVermaMD · X

More evidence for effectiveness of SGLT2 inhibitors for improving cardiac dysfunction? This is a great summary of the mechanisms of SGLT2i for treatment of diabetic cardiomyopathy: https://t.co/2Hg5E4JYKY @BioMedCentral #MedTwitter #CardioTwitter https://t.co/Wajuf5nNXX

May 10, 2023 · 12 likes · 2 shares · 1,195 followers View post →
Journal of Diabetes & Metabolism, ISSN-2155-6156
@JDiabetesMetab · X

#callforpapers #Submissionsopen #Articles #manuscript https://t.co/BFb4Ol4dBv Submit manuscript at: https://t.co/OHP9K9OhYK Email: jdm@emedicalsciences.com #diabetes #type1diabetes #Health #healthy #HealthyLiving

Apr 14, 2023 · 391 followers View post →

All mentions

Subodh Verma
@SubodhVermaMD · X

More evidence for effectiveness of SGLT2 inhibitors for improving cardiac dysfunction? This is a great summary of the mechanisms of SGLT2i for treatment of diabetic cardiomyopathy: https://t.co/2Hg5E4JYKY @BioMedCentral #MedTwitter #CardioTwitter https://t.co/Wajuf5nNXX

May 10, 2023 · 12 likes · 2 shares · 1,195 followers View post →
Journal of Diabetes & Metabolism, ISSN-2155-6156
@JDiabetesMetab · X

#callforpapers #Submissionsopen #Articles #manuscript https://t.co/BFb4Ol4dBv Submit manuscript at: https://t.co/OHP9K9OhYK Email: jdm@emedicalsciences.com #diabetes #type1diabetes #Health #healthy #HealthyLiving

Apr 14, 2023 · 391 followers View post →